Co-Transcriptional Regulation of HBV Replication: RNA Quality Also Matters
Viruses · 2024
DOI: 10.3390/v16040615 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, 2024. Verfasst von Guillaume Giraud und 3 weiteren Autor:innen. Beteiligte Einrichtung: INSERM U1052, CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, Université Claude Bernard Lyon 1, 69008 Lyon, France. Hauptthemen laut MEDLINE: Hepatitis B virus, Virus Replication, RNA, Viral, Gene Expression Regulation, Viral. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche, Agence Nationale de Recherches sur le Sida et les Hépatites Virales, “Investissement d’avenir” Laboratoires d’Excellence (LabEx) DEVweCAN (Cancer Development and Targeted Therapies).
Abstract (Originalsprache)
Chronic hepatitis B (CHB) virus infection is a major public health burden and the leading cause of hepatocellular carcinoma. Despite the efficacy of current treatments, hepatitis B virus (HBV) cannot be fully eradicated due to the persistence of its minichromosome, or covalently closed circular DNA (cccDNA). The HBV community is investing large human and financial resources to develop new therapeutic strategies that either silence or ideally degrade cccDNA, to cure HBV completely or functionally. cccDNA transcription is considered to be the key step for HBV replication. Transcription not only influences the levels of viral RNA produced, but also directly impacts their quality, generating multiple variants. Growing evidence advocates for the role of the co-transcriptional regulation of HBV RNAs during CHB and viral replication, paving the way for the development of novel therapies targeting these processes. This review focuses on the mechanisms controlling the different co-transcriptional processes that HBV RNAs undergo, and their contribution to both viral replication and HBV-induced liver pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- INSERM U1052, CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, Université Claude Bernard Lyon 1, 69008 Lyon, France.
- The Lyon Hepatology Institute EVEREST, 69003 Lyon, France.
- Hospices Civils de Lyon, Hôpital Croix Rousse, Service d'Hépato-Gastroentérologie, 69004 Lyon, France.
ORCID-Profile: Guillaume Giraud, Khadija El Achi, Fabien Zoulim, Barbara Testoni
Förderung
- Agence Nationale de la Recherche
- Agence Nationale de Recherches sur le Sida et les Hépatites Virales
- “Investissement d’avenir” Laboratoires d’Excellence (LabEx) DEVweCAN (Cancer Development and Targeted Therapies)
- French Agence Nationale de Recherche sur le Sida, les hépatites virales et les maladies infectieuses émérgentes (ANRS|MIE)
Zitieren
APA
Giraud, G., El Achi, K., Zoulim, F., & Testoni, B. (2024). Co-Transcriptional Regulation of HBV Replication: RNA Quality Also Matters. Viruses. https://doi.org/10.3390/v16040615
Vancouver
Giraud G, El Achi K, Zoulim F, Testoni B. Co-Transcriptional Regulation of HBV Replication: RNA Quality Also Matters. Viruses. 2024. doi:10.3390/v16040615
BibTeX
@article{Giraud2024,
author = {Giraud, Guillaume and El Achi, Khadija and Zoulim, Fabien and Testoni, Barbara},
title = {Co-Transcriptional Regulation of HBV Replication: RNA Quality Also Matters},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16040615}
}
EUVIMED